Yasushi Horimasu

Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis

Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu et al. · Respiratory Medicine · 2014 · 204 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +14

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis

Kosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa et al. · Disease Markers · 2016 · 149 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +15

<scp><i>MUC</i></scp><i>5</i><scp><i>B</i></scp> promoter polymorphism in <scp>J</scp>apanese patients with idiopathic pulmonary fibrosis

Yasushi Horimasu, Shinichiro Ohshimo, Francesco Bonella et al. · Respirology · 2015 · 120 citations

Medicine, Genetics, Molecular Genetics +14

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

Yu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi et al. · Respiratory Investigation · 2019 · 119 citations

Medicine, Immunology, Oncology +16

Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels

Yasushi Horimasu, Noboru Hattori, Nobuhisa Ishikawa et al. · Respiratory Medicine · 2012 · 71 citations · Full text

Life Sciences, Genetics, Molecular Genetics +5